Clinical Trials Directory

Trials / Completed

CompletedNCT01550627

Effect of Intravenous Fluid Supplementation on Serum Bilirubin and Cardiorespiratory Parameters in Preterm Infants During Phototherapy

Study of Possible Effects of Intravenous Fluid Supplementation on Serum Bilirubin Levels and Cardiorespiratory Parameters in Preterm Infants During Phototherapy

Status
Completed
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
60 (actual)
Sponsor
University of Jena · Academic / Other
Sex
All
Age
1 Week – 1 Week
Healthy volunteers
Not accepted

Summary

The aim of the study was to evaluate the influence of a systematic extra intravenous fluid supplementation during phototherapy in comparison to a fluid supplementation due to short term demand in preterm infants.

Detailed description

60 preterm infants (GA ≤ 32 week) were assigned randomly to either receive a fluid supplementation due to short term demand (control group, n=30;) or a 20% extra fluid supplementation (study group, n=30) during intermediate phototherapy. Collected data: * cardiorespiratory parameters(heart rate, blood pressure, SaO2 and capillary refill time, breathing rate, temperature) and a pain score was completed at the first day of phototherapy * The maximum total serum bilirubin levels (TSB) within one week after onset of phototherapy

Conditions

Interventions

TypeNameDescription
OTHERextra fluid/iv fluid supplementation during phototherapyThe study group received an extra intravenous fluid intake of 20% of the total fluid demand per 24 hours of NaCl 0,9% during each two hour period of phototherapy (12h total per day). The extra fluid intake was interrupted during the 12 hours break of phototherapy.
OTHERNon extra fluidControl placebo The control group received the previous fluid regime, as intravenous fluid was given constantly, without a specific guideline according to extra fluid intake.

Timeline

Start date
2007-11-01
Primary completion
2009-06-01
Completion
2009-06-01
First posted
2012-03-12
Last updated
2012-03-12

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT01550627. Inclusion in this directory is not an endorsement.